Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Two deals for Domain
April 2020
SHARING OPTIONS:

STRASBOURG, France—Domain Therapeutics kicked March off with the acquisition of all shares in PC SAS (Prestwick Chemical) and Neurofit (SAS) both of which are former subsidiaries of Bionomics Ltd. The transaction boosts Domain’s portfolio and its footprint in certain therapeutic areas. Acquiring Prestwick Chemical doubles Domain’s medicinal chemistry resources, enabling the company to increase its capacity for internal programs and pharma collaborations. Neurofit will continue its service-based activities in conjunction with providing Domain with an animal pharmacology platform in neurological diseases, according to a Domain press release.
 
“These acquisition opportunities perfectly match Domain’s need to strengthen its core scientific capabilities in order to pursue its growth in the coming years,” said Domain CEO Pascal Neuville. “The addition of these new capabilities will significantly streamline the expansion of our project portfolio and reinforce our partnering capacity.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.